Liu Yue Yin - Net Worth and Insider Trading

Liu Yue Yin Net Worth

The estimated net worth of Liu Yue Yin is at least $67,200 dollars as of 2024-06-22. Liu Yue Yin is the Securities Affairs Representative of Harbin Gloria Pharmaceuticals Co Ltd and owns about 38,400 shares of Harbin Gloria Pharmaceuticals Co Ltd (SZSE:002437) stock worth over $67,200. Details can be seen in Liu Yue Yin's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Liu Yue Yin has not made any transactions after 2017-02-07 and currently still holds the listed stock(s).

Transaction Summary of Liu Yue Yin

To

Liu Yue Yin Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Liu Yue Yin owns 1 companies in total, including Harbin Gloria Pharmaceuticals Co Ltd (SZSE:002437) .

Click here to see the complete history of Liu Yue Yin’s form 4 insider trades.

Insider Ownership Summary of Liu Yue Yin

Ticker Comapny Transaction Date Type of Owner
SZSE:002437 Harbin Gloria Pharmaceuticals Co Ltd 2017-02-07 Securities Affairs Representative

Liu Yue Yin Latest Holdings Summary

Liu Yue Yin currently owns a total of 1 stock. Liu Yue Yin owns 38,400 shares of Harbin Gloria Pharmaceuticals Co Ltd (SZSE:002437) as of February 7, 2017, with a value of $67,200.

Latest Holdings of Liu Yue Yin

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SZSE:002437 Harbin Gloria Pharmaceuticals Co Ltd 2017-02-07 38,400 1.75 67,200

Holding Weightings of Liu Yue Yin


Liu Yue Yin Form 4 Trading Tracker

According to the SEC Form 4 filings, Liu Yue Yin has made a total of 0 transactions in Harbin Gloria Pharmaceuticals Co Ltd (SZSE:002437) over the past 5 years. The most-recent trade in Harbin Gloria Pharmaceuticals Co Ltd is the sale of 69,200 shares on February 7, 2017, which brought Liu Yue Yin around $615,188.

Insider Trading History of Liu Yue Yin

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Liu Yue Yin Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Liu Yue Yin Ownership Network

Ownership Network List of Liu Yue Yin

No Data

Ownership Network Relation of Liu Yue Yin

Insider Network Chart

Liu Yue Yin Owned Company Details

What does Harbin Gloria Pharmaceuticals Co Ltd do?

Who are the key executives at Harbin Gloria Pharmaceuticals Co Ltd?

Liu Yue Yin is the Securities Affairs Representative of Harbin Gloria Pharmaceuticals Co Ltd. Other key executives at Harbin Gloria Pharmaceuticals Co Ltd include Independent director Guo Yun Pei , Supervisors Wang Yu , and Directors & executives Diao Xiu Qiang .

Harbin Gloria Pharmaceuticals Co Ltd (SZSE:002437) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Harbin Gloria Pharmaceuticals Co Ltd (SZSE:002437) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Harbin Gloria Pharmaceuticals Co Ltd (SZSE:002437) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Harbin Gloria Pharmaceuticals Co Ltd (SZSE:002437)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Harbin Gloria Pharmaceuticals Co Ltd Insider Transactions

No Available Data

Liu Yue Yin Mailing Address

Above is the net worth, insider trading, and ownership report for Liu Yue Yin. Currently GuruFocus does not have mailing address information for Liu Yue Yin.

Discussions on Liu Yue Yin

No discussions yet.